Clinical evaluation of traditional Chinese medicine regimen in the treatment of patients with lumbar intervertebral disc herniation in the non-acute stage

Research on the efficacy and evidence-based evaluation of traditional Chinese medicine programs for lumbar intervertebral disc herniation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053158

Enrollment

Unknown

Registered

2021-11-13

Start date

2021-11-15

Completion date

Unknown

Last updated

2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Interventions

experimental group 1:Yaobitong capsule

experimental group 2:Lumbar spine standard manipulation

experimental group 3:Yaobitong capsule + lumbar spine standard manipulation

control group:No intervention for the first 14 days, and compensatory treatment after 14 days

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient aged between 18 and 70 years, MRI confirmed lumbar disc herniation, clinical symptoms are leg pain extending below the knee, and the MRI corresponds to the nerve root distribution area; 2. The course of lumbar and leg pain of lumbar intervertebral disc herniation is more than 3 months, and the time point of the latest acute recurrence is more than 3 months; 3. The patient's leg pain VAS >= 4.0 points and < 7 points.

Exclusion criteria

Exclusion criteria: 1. Previous lumbar spine surgery; 2. Received oral or epidural steroid therapy in the past 3 months; 3. Suffering from severe diabetes with peripheral neuropathy, severe osteoporosis, gastric ulcer, gastrointestinal bleeding, spinal tumor, spinal tuberculosis, spinal compression fracture; 4. Allergic to non-steroidal drugs and Chinese medicine; 5. Symptoms of cauda equina damage, or substantial and progressive motor function loss; 6. Patients with litigation or legal claims issues.

Design outcomes

Secondary

Measure	Time frame
Low back pain visual analogue scale score;The Oswestry Disability Index (ODI);Japanese Orthopaedic Association Lumbar Score;Health Survey 12-Item Short Form (SF-12);X-ray of lumbar spine;Magnetic resonance imaging (MRI) of the lumbar spine;	—

Primary

Measure	Time frame
Lower extremity pain visual analogue scale score;	—

Countries

China

Contacts

Public ContactLeng Xiangyang

Affiliated Hospital of Changchun University of Traditional Chinese Medicine

Lengxy@163.com+86 15948000708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026